SKLB325
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-139782-5MG | 5 mg | 456,00 | Add | |
| HY-139782-1ML | 10mM/1mL | 501,00 | Add | |
| HY-139782-10MG | 10 mg | 673,00 | Add | |
| HY-139782-25MG | 25 mg | 1'255,00 | Add | |
| HY-139782-50MG | 50 mg | 1'812,00 | Add | |
| HY-139782-100MG | 100 mg | 2'484,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
SKLB325 is a Jumonji domain-containing 6 (JMJD6) inhibitor with a binding affinity (KD) value of 0.755 μM, and the IC50 value of 0.7797 μM. SKLB325 exhibits antitumor effects on ovarian cancer in vivo and in vitro. SKLB325 induces apoptosis[1]. SKLB325 exhibits remarkable antitumor efficacy in renal cell carcinoma (RCC) [2].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Apoptosis,Epigenetics |
| Format | Solubility: DMSO : 20.83 mg/mL (ultrasonic;warming;heat to 60°C) |
| Grade | Clinical information: No Development Reported |
| Purity | 99.79% |
| Molecular Formula | C12H12N4O2 |
| Molecular Weight | 244.25 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
